• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[利用体外BrdU标记法和抗BrdU单克隆抗体对泌尿生殖系统肿瘤进行细胞动力学研究]

[Cell kinetic study of urogenital tumors utilizing in vitro BrdU-labelling method and anti-BrdU monoclonal antibody].

作者信息

Shimabukuro T, Yamamoto M, Mitsui H, Yamamoto N, Sakatoku J, Harada H, Sacho T

机构信息

Department of Urology, Yamaguchi University School of Medicine.

出版信息

Hinyokika Kiyo. 1989 Aug;35(8):1285-90.

PMID:2816596
Abstract

With the aim to apply a rapid analytic method of cell kinetics using in vitro BrdU labelling and anti-BrdU monoclonal antibody to the clinical fields, we investigated the cell kinetics of 20 urogenital malignant tumors. The DNA synthesizing cells which take up BrdU in its nuclei can be detected so clearly, since the labelling index (LI) is easily identified. The correlations between LI and age and with histological grade and stage of 14 transitional cell cancers of urinary tract were investigated. There was no correlation between LI and age. The LI of high grade groups (G2 & G3) were significantly higher than that of the low grade group (G1) (p less than 0.05). Also between LI of pT1 group and pT3 group, there was a statistical significance (p less than 0.05) and generally LI tended to increase according to stage progression. Therefore, the cytokinetic data obtained from the before mentioned method can be utilized as a useful marker for measuring malignant potentials of each tumor.

摘要

为了将使用体外BrdU标记和抗BrdU单克隆抗体的细胞动力学快速分析方法应用于临床领域,我们研究了20例泌尿生殖系统恶性肿瘤的细胞动力学。由于易于识别标记指数(LI),因此可以清晰地检测到细胞核中摄取BrdU的DNA合成细胞。研究了14例泌尿系统移行细胞癌的LI与年龄、组织学分级和分期之间的相关性。LI与年龄之间无相关性。高级别组(G2和G3)的LI显著高于低级别组(G1)(p<0.05)。此外,pT1组和pT3组的LI之间存在统计学意义(p<0.05),并且一般来说LI倾向于随着分期进展而增加。因此,从上述方法获得的细胞动力学数据可作为衡量各肿瘤恶性潜能的有用标志物。

相似文献

1
[Cell kinetic study of urogenital tumors utilizing in vitro BrdU-labelling method and anti-BrdU monoclonal antibody].[利用体外BrdU标记法和抗BrdU单克隆抗体对泌尿生殖系统肿瘤进行细胞动力学研究]
Hinyokika Kiyo. 1989 Aug;35(8):1285-90.
2
[Non-urothelial tumors of the urinary tract].[泌尿道非尿路上皮肿瘤]
Verh Dtsch Ges Pathol. 1993;77:180-98.
3
Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.上尿路移行细胞癌行肾输尿管切除术或输尿管节段切除术后膀胱肿瘤的病理特征。
Urology. 2007 Feb;69(2):251-4. doi: 10.1016/j.urology.2006.09.065.
4
Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma.p63和p53表达在上尿路移行细胞癌中的预后影响
Urology. 2004 Jun;63(6):1079-83. doi: 10.1016/j.urology.2004.01.009.
5
Expression of p27 and its ubiquitin ligase subunit Skp2 in upper urinary tract transitional cell carcinoma.p27及其泛素连接酶亚基Skp2在上尿路移行细胞癌中的表达
Urology. 2004 Sep;64(3):611-6. doi: 10.1016/j.urology.2004.04.072.
6
[Association of uPA and uPAR expression with invasive behaviors of urinary transitional cell carcinoma].尿激酶型纤溶酶原激活物(uPA)及尿激酶型纤溶酶原激活物受体(uPAR)表达与尿路上皮癌侵袭行为的相关性
Ai Zheng. 2004 Jun;23(6):704-6.
7
Urothelial carcinoma of the upper urinary tract: comparison between the WHO/ISUP 1998 consensus classification and WHO 1999 classification system.上尿路尿路上皮癌:WHO/ISUP 1998共识分类与WHO 1999分类系统的比较
Urology. 2005 Aug;66(2):274-8. doi: 10.1016/j.urology.2005.03.011.
8
[Clinical studies on renal pelvic and ureteral carcinoma].[肾盂及输尿管癌的临床研究]
Hinyokika Kiyo. 1997 Apr;43(4):257-62.
9
[Cell kinetic study of human carcinomas using bromodeoxyuridine and immunohistochemistry].[使用溴脱氧尿苷和免疫组织化学对人类癌症进行细胞动力学研究]
Nihon Geka Gakkai Zasshi. 1989 Mar;90(3):355-63.
10
Transitional cell carcinoma of the upper urinary tract: analysis of morphology and distribution for surgical management.上尿路移行细胞癌:手术治疗的形态学与分布分析
Jpn J Clin Oncol. 1993 Oct;23(5):303-8.

引用本文的文献

1
Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part II: Oncology, chemotherapy and carcinogenesis.溴脱氧尿苷:生物学与医学中的诊断工具,第二部分:肿瘤学、化疗与致癌作用
Histochem J. 1995 Dec;27(12):923-64.